Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b

Microbiology and Immunology

Volumn 42, Issue 4, 1998, Pages 299-303

  Sakugawa, Hiroshi ^a   Nakasone, Hiroki ^a   Nakayoshi, Tomofumi ^a   Kawakami, Yuko ^a   Kinjo, Fukunori ^a   Saito, Atsushi ^a   Nakayoshi, Tomokuni ^b   Yamashiro, Akihiro ^c  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Yonabaru Central Hospital   (Japan)

^c Hokubuchiku Ishikai Hospital   (Japan)

Author keywords

Hepatitis C virus; Non structural region; Recombinant immunoblot assay

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; VIRUS TYPING;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031957095     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1998.tb02286.x     Document Type: Article

References (26)

1. Bhattacherjee, V., Prescott, L.E., Pike, I., Rodgers, B., Bell, H., El-Zayadi, A.R., Kew, M.C., Conradie, J., Lin, C.K., Marsden, H., Saeed, A.A., Parker, D., Yap, P.L., and Simmonds, P. 1995. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J. Gen. Virol. 76: 1737-1748.
2. Bukh, J., Miller, R.H., and Purcell, R.H. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15: 43-63.
3. Choo, Q.-L., Richman, K.H., Han, J.H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, A., Barr, P.J., Weiner, A.J., Bradley, D.W., Kuo, G., and Houghton, M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88: 2451-2455.
4. Desmet, V.J., Gerber, M., Hoofnagle, J.H., Manns, M., and Scheuer, P.J. 1994. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520.
5. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., and Ogura, Y. 1996. Mutation in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334: 77-81.
6. Hino, K., Sainokami, S., Shimoda, K., Iino, S., Wang, Y., Okamoto, H., Miyakawa, Y., and Mayumi, M. 1994. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J. Med. Virol. 42: 299-305.
7. Hotta, H., Doi, H., Hayashi, T., Purwanta, M., Soemarto, W., Mizokami, M., Ohba, K., and Honma, M. 1994. Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia. Arch. Virol. 136: 53-62.
8. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T., and Shimotono, K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U.S.A. 87: 9524-9528.
9. Kobayashi, M., Tanaka, E., Sodeyama, T., Urushibata, A., Matsumoto, A., and Kiyosawa, K. 1996. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 23: 695-699.
10. Kuo, G., Choo, Q.L., Alter, H.J., Gitnick, G.L., Redeker, A.G., Purcell, R.H., Miyamura, T., Colombo, M., Lee W.S., Kuo, C., Berger, K., Shuster, J.R., Overby, L.R., Bradley, D.W., and Houghton, M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364.
11. McOmish, F., Chan, S.-W., Dow, B.C., Gillon, J., Frame, W.D., Crawford, R.J., Yap, P.L., Follett, E.A.C., and Simmonds, P. 1993. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33: 7-13.
12. Okamoto, H., Okada, S., Sugiyama, Y., Yotsumoto, S., Tanaka, T., Yoshizawa, H., Tsuda, F., Miyakawa, Y., and Mayumi, M. 1990. The 5′-terminal sequence of the hepatitis C virus genotype. Jpn. J. Exp. Med. 60: 167-177.
13. Okamoto, H., Kojima, M., Okada, S., Yoshizawa, H., Iizuka, H., Tanaka, T., Muchmore, E.E., Peterson, D.A., Ito, Y., and Mishiro, S. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190: 894-899.
14. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y., and Mayumi, M. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: amplification to clinical surveys and tracing infectious sources. J. Gen. Virol. 73: 673-679.
15. Pawlotsky, J.M., Roudot-Thoraval, F., Pellet, C., Aumont, P., Darthuy, F., Remire, J., Duval, J., and Dhumeaux, D. 1995. Influence of hepatitis C virus (HCV) genotype on HCV recombinant immunoblot assay patterns. J. Clin. Microbiol. 33: 1357-1359.
16. Qu, D., Li, J.-S., Vitvitski, L., Mechai, S., Berby, F., Tong, S.-P., Baily, F., Wang, Q.-S., Martin, J.-L., and Trepo, C. 1994. Hepatitis C virus in France: comparison of clinical features of patients infected with type 1 and type 2. J. Hepatol. 21: 70-75.
17. Sakugawa, H., Nakasone, H., Kinjo, F., Saito, A., Keida, Y., Kikuchi, K., Oyadomari, Y., Ishihara, M., Nakasone, K., Yogi, S., Kinjo, Y., and Taira, M. 1997. Clinical features of patients with chronic liver disease associated with hepatitis C virus genotype 1a in Okinawa, Japan. J. Gastroenterol. Hepatol. 12: 176-181.
18. Simmonds, P., Holmes, E.C., Cha, T.-A., Chan, S.-W., McOmish, F., Irvine, B., Beall, E., Yap, P.L., Kolberg, J., and Urdea, M.S. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74: 2391-2399.
19. Simmonds, P., Rose, K.A., Graham, S., Chan, S.-W., McOmish, F., Dow, B.C., Follett, E.A.C., Yap, P.L., and Marsden, H. 1993. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with types 1, 2 and 3. J. Clin. Microbiol. 31: 1493-1503.
20. Takada, N., Takase, S., Enomoto, N., Takada, A., and Date, T. 1992. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J. Hepatol. 14: 35-40.
21. Takamizawa, A., Mori, C., Fuke, I., Manabe, S., Murakami, S., Fujita, J., Onishi, E., Andoh, T., Yoshida, I., and Okayama, H. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65: 1105-1113.
22. Tanaka, E., Kiyosawa, K., Matsushima, T., Ishikawa, K., Hino, K., Tanaka, S., Nose, H., Kumada, H., Iino, S., Kamimura, T., Unoura, M., Mizokami, M., Okanoue, T., Kuroki, T., Yamada, G., Miura, T., Yano, M., Tsubouchi, H., Kohara, M., Sato, S., Hattori, N., and Genotype ELISA Study Group. 1995. Epidemiology of genotype of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multiinstitution analysis. J. Gastroenterol. Hepatol. 10: 538-545.
23. Tanaka, T., Tsukiyama-Kohara, K., Yamaguchi, K., Yagi, S., Tanaka, S., Hasegawa, A., Ohta, Y., Hattori, N., and Kohara, M. 1994. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 19: 1347-1353.
24. Tsukiyama-Kohara, K., Kohara, M., Yamaguchi, K., Maki, N., Toyoshima, A., Miki, K., Tanaka, S., Hattori, N., and Nomoto, A. 1991. A second group of hepatitis C viruses. Virus Genes 5: 243-254.
25. Tsukiyama-Kohara, K., Yamauchi, K., Maki, N., Ohta, Y., Miki, K., Mizokami, M., Ohba, K., Tanaka, S., Hattori, N., Nomoto, A., and Kohara, M. 1993. Antigenicities of group 1 and group 2 hepatitis C virus polypeptides - molecular basis of diagnosis. Virology 192: 430-437.
26. Zhang, Z.-X., Yun, Z.-B., Chen, M., Sonnerborg, A., and Sallberg, M. 1995. Evaluation of a multiple peptide assay for typing of antibody to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction. J. Med. Virol. 45: 50-55.